Core and Group Health

Observers say that while capping the cost of insulin at $35 a month benefits consumers, it doesn't strengthen Lilly's legal arguments since the company and others raised list prices by 150% over five years, alleges one lawsuit.

"Junk plans are leaving Americans with these tremendously expensive bills," says Xavier Becerra, secretary of Health and Human Services.

Many surgical procedures proved to be pricier for hospitals in the network.

Human resources departments and benefits administrators may want to review offerings to support employee health.

Facing pressure to curb diabetes treatment costs, the price cut puts the drugmaker's insulin in line with the Inflation Reduction Act, which last month capped the medication's cost for seniors on Medicare.

Fertility and adoption benefits have been rapidly increasing over the last seven years to attract and retain talent, to save on health care costs and to match diversity, equity and inclusion efforts, according to a new study.